Marvell Technology, Inc. Investing Cash Flow increased by 96.3% to -$94.10M in Q1 2025 compared to the prior quarter. Year-over-year, this metric grew by 7.7%, from -$101.90M to -$94.10M. Over 2 years (FY 2023 to FY 2025), Investing Cash Flow shows relatively stable performance with a -4.3% CAGR.
A negative value typically signals investment in future growth, while a positive value may indicate divestment or the maturity of a large investment portfolio.
This metric is the net total of all cash inflows and outflows related to investing activities, including capital expendi...
Most mature healthcare companies maintain a negative net investing cash flow due to ongoing R&D and infrastructure investment.
net_cash_from_investing| Q1 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$3.62B | -$51.90M | -$3.48B | -$82.40M | -$137.30M | -$54.60M | -$54.10M | -$102.70M | -$52.20M | -$75.50M | -$120.10M | -$101.90M | -$69.40M | $2.39B | -$2.52B | -$94.10M |
| QoQ Change | — | +98.6% | <-999% | +97.6% | -66.6% | +60.2% | +0.9% | -89.8% | +49.2% | -44.6% | -59.1% | +15.2% | +31.9% | >999% | -205.4% | +96.3% |
| YoY Change | — | — | — | +97.7% | — | -5.2% | +98.4% | -24.6% | +62.0% | -38.3% | -122.0% | +0.8% | -33.0% | >999% | <-999% | +7.7% |